The global Anatomic Pathology Market is experiencing strong growth due to the rising prevalence of cancer and chronic diseases, increasing demand for tissue-based diagnostics, and rapid advancements in digital pathology technologies. Healthcare providers are increasingly relying on anatomic pathology for accurate disease diagnosis, classification, staging, and treatment planning,...
The global Molecular Diagnostics Market size was valued at USD 18.8 billion in 2025 and is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033. North America dominated the market with a 44.1% revenue share in 2025. The growth of the molecular diagnostics industry is driven by increasing...
Antiviral Drugs Market: Advancing Global Healthcare Through Innovative Antiviral Therapies
Antiviral Drugs Market Snapshot
The Antiviral Drugs Market is witnessing stable growth as the global burden of viral infections continues to drive demand for effective therapeutic solutions. According to M2Square Consultancy, the global Antiviral Drugs Market was valued...
The global Bioinformatics Services Market is rapidly expanding, driven by advances in biology, IT, and computation that support the analysis and management of large-scale biological data. Valued around USD 4.6 billion in 2025, the market is projected to reach approximately USD 12.4 billion by 2033, growing at a CAGR of about 13.5%. The growth is fueled by the rising demand for...
"Biomarker-Driven Targeted Drug Market Summary:
According to the latest report published by Data Bridge Market Research, the Biomarker-Driven Targeted Drug Market
The global biomarker-driven targeted drug market size was valued at USD 12.63 billion in 2025 and is expected to reach USD 33.10 billion by 2033, at a CAGR of 12.80% during the forecast period...
According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...
Cancer Genetic Testing Industry Insights:
Straits Research recently introduced the latest update on the Cancer Genetic Testing Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Cancer Genetic Testing...
According to a report by Intel Market Research, the global Companion Diagnostics Market was valued at USD 7.1 billion in 2025 and is projected to grow from USD 7.8 billion in 2026 to USD 14.3 billion by 2034, exhibiting a CAGR of 8.1% during the forecast period. The market is expanding rapidly as precision medicine becomes an integral component of modern healthcare, particularly in oncology....
Microfluidics Market: Transforming Precision Diagnostics, Drug Discovery, and Point-of-Care Healthcare
Microfluidics Market Snapshot
The Microfluidics Market is witnessing remarkable growth as miniaturized fluid-handling technologies revolutionize healthcare diagnostics, life sciences research, pharmaceutical development, and industrial applications. According to M2Square...
According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...
English
Indonesia
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek